A randomized controlled trial of amantadine plus interferon-alpha2a vs. interferon-alpha2a alone in naive patients with chronic hepatitis C randomized according to the early virological response to interferon-alpha2a monotherapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples